Human immunoglobulin A (IgA)-specific ligands from combinatorial engineering of protein A

European Journal of Biochemistry

Volumn 269, Issue 11, 2002, Pages 2647-2655

  Rönnmark, Jenny ^a   Grönlund, Hans ^b   Uhlén, Mathias ^a   Nygren, Per Åke ^a  

^a ROYAL INSTITUTE OF TECHNOLOGY   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Affibody; Affinity ligand; Combinatorial protein engineering; IgA; Phage display

Indexed keywords

IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN A1; IMMUNOGLOBULIN A2; IMMUNOGLOBULIN D; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PROTEIN A; SECRETORY IMMUNOGLOBULIN;

AFFINITY CHROMATOGRAPHY; ARTICLE; BINDING AFFINITY; BIOSENSOR; CONTROLLED STUDY; CROSS REACTION; DISSOCIATION CONSTANT; DNA SEQUENCE; ESCHERICHIA COLI; MOLECULE; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DOMAIN;

ANTIBODIES, MONOCLONAL; HUMANS; IMMUNOGLOBULIN A; LIGANDS; PROTEIN ENGINEERING; STAPHYLOCOCCAL PROTEIN A;

ESCHERICHIA COLI;

EID: 0036275295     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1432-1033.2002.02926.x     Document Type: Article

References (36)

1. Receptins: A novel term for an expanding spectrum of natural and engineered microbial proteins with binding properties for mammalian proteins
2. Applications of immobilized protein A in immunochemical techniques
3. Crystal structure of a Staphylococcus aureus protein A domain complexed with the Fab fragment of a human IgM antibody: Structural basis for recognition of B-cell receptors and superantigen activity
4. Staphylococcal protein A simultaneously interacts with framework region 1, complementarity-determining region 2, and framework region 3 on human VH3-encoded Igs
5. The use of gene fusions to protein A and protein G in immunology and biotechnology
6. Structure and evolution of the repetitive gene encoding streptococcal protein G
7. Purification of staphylococcal protein A using immunosorbents
8. Protein L from Peptostreptococcus magnus binds to the kappa light chain variable domain
9. Purification of antibodies using protein L-binding framework structures in the light chain variable domain
10. Location and structural significance of the oligosaccharides in human IgA1 and IgA2 immunoglobulins
11. Immunoglobulin A (IgA): Molecular and cellular interactions involved in IgA biosynthesis and immune response
12. Interaction of antigens and antibodies at mucosal surfaces
13. Pathogenesis of IgA nephropathy
14. IgA antibodies to gliadin and coeliac disease in psoriatic arthritis
15. Henoch-Schönlein purpura
16. Local synthesis of IgA in the cerebrospinal fluid of patients with neurological diseases
17. IgA antibodies for cancer therapy
18. An IgA-binding peptide derived from a streptococcal surface protein
19. Streptococcal IgA-binding proteins bind in the Cα2-Cα3 interdomain region and inhibit binding of IgA to human CD89
20. Protein B: A versatile bacterial Fc-binding protein selective for human IgA
21. A combinatorial library of an α-helical bacterial receptor domain
22. Binding proteins selected from combinatorial libraries of an α-helical bacterial receptor domain
23. Protection against respiratory syncytial virus (RSV) elicited in mice by plasmid DNA immunisation encoding a secreted RSV G protein-derived antigen
24. Ligands selected from combinatorial libraries of protein A for use in affinity capture of apolipoprotein A-1M and Taq DNA polymerase
25. Recombinant human factor VIII-specific affinity ligands selected from phage-displayed combinatorial libraries of protein A
26. pUR 250 allows rapid chemical sequencing of both DNA strands of its inserts
27. Gene regulation at the right operator (OR) bacteriophage lambda I. OR3 and autogenous negative control by repressor
28. A molecular model of type I allergy: Identification and characterization of a nonanaphylactic anti-human IgE antibody fragment that blocks the IgE-FcεRI interaction and reacts with receptor-bound IgE
29. Affinity maturation of a Taq DNA polymerase specific affibody by helix shuffling
30. Affinity chromatography in the industrial purification of plasma proteins for therapeutic use
31. Characterization of an IgA receptor from group B streptococci: Specificity for serum IgA
32. Crystal structure of the C2 fragment of streptococcal protein G in complex with the Fc domain of human IgG
33. Self-reactive antibodies (natural autoantibodies) in healthy individuals
34. Clinical trials of antibody therapy
35. Performance comparison of protein A affinity-chromatography sorbents for purifying recombinant monoclonal antibodies
36. Characterization of a recombinant plant monoclonal secretory antibody and preventive immunotherapy in humans